156 related articles for article (PubMed ID: 27316759)
1. Prediction of hepatic cyst recurrence after minocycline hydrochloride aspiration sclerotherapy using cyst computed tomography values.
Iijima T; Suwabe T; Sumida K; Hayami N; Mise K; Hoshino J; Takaichi K; Ubara Y
Hepatol Res; 2017 Apr; 47(5):419-424. PubMed ID: 27316759
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous sclerotherapy using a 4 F pigtail catheter and 40 milliliters of 5% ethanolamine oleate for symptomatic large hepatic cysts.
Miyayama S; Yamashiro M; Ikeda R; Matsumoto J; Ogawa N; Notsumata K
Diagn Interv Radiol; 2022 Mar; 28(2):149-155. PubMed ID: 35548899
[TBL] [Abstract][Full Text] [Related]
3. Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.
Neijenhuis MK; Wijnands TFM; Kievit W; Ronot M; Gevers TJG; Drenth JPH
Eur Radiol; 2019 Jun; 29(6):3062-3068. PubMed ID: 30542749
[TBL] [Abstract][Full Text] [Related]
4. Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease.
Erdogan D; van Delden OM; Rauws EA; Busch OR; Lameris JS; Gouma DJ; van Gulik TM
World J Gastroenterol; 2007 Jun; 13(22):3095-100. PubMed ID: 17589926
[TBL] [Abstract][Full Text] [Related]
5. Cyst sclerotherapy with minocycline hydrochloride in patients with autosomal dominant polycystic kidney disease.
Uemasu J; Fujihara M; Munemura C; Nakamura E; Kawasaki H
Nephrol Dial Transplant; 1996 May; 11(5):843-6. PubMed ID: 8671906
[TBL] [Abstract][Full Text] [Related]
6. Monoethanolamine Oleate Sclerotherapy for Polycystic Liver Disease.
Takita M; Iwanishi M; Minami T; Kono M; Chishina H; Arizumi T; Yada N; Hagiwara S; Minami Y; Ida H; Ueshima K; Naoshi N; Kudo M
Dig Dis; 2016; 34(6):654-658. PubMed ID: 27750233
[TBL] [Abstract][Full Text] [Related]
7. Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial.
Wijnands TFM; Gevers TJG; Lantinga MA; Te Morsche RH; Schultze Kool LJ; Drenth JPH
Eur Radiol; 2018 Jun; 28(6):2682-2689. PubMed ID: 29318424
[TBL] [Abstract][Full Text] [Related]
8. Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data.
Wijnands TF; Ronot M; Gevers TJ; Benzimra J; Kool LJ; Vilgrain V; Drenth JP
Eur Radiol; 2017 Feb; 27(2):741-748. PubMed ID: 27180184
[TBL] [Abstract][Full Text] [Related]
9. Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial.
Wijnands TF; Gevers TJ; Kool LJ; Drenth JP
Trials; 2015 Mar; 16():82. PubMed ID: 25873132
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of minocycline hydrochloride aspiration sclerotherapy with additional monoethanolamine oleate aspiration sclerotherapy for symptomatic hepatic cysts.
Kimura Y; Fujiwara K; Matsuura K; Suzuki T; Senoo K; Tsuchida K; Mori Y; Hirano A; Nomura S; Kitagawa M; Tomita Y; Kanaiwa H; Imazu M; Nagura Y; Nojiri S; Kataoka H
Hepatol Res; 2023 Mar; 53(3):267-275. PubMed ID: 36479738
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic hepatic cysts: treatment with single-shot injection of minocycline hydrochloride.
Cellier C; Cuenod CA; Deslandes P; Auroux J; Landi B; Siauve N; Barbier JP; Frija G
Radiology; 1998 Jan; 206(1):205-9. PubMed ID: 9423674
[TBL] [Abstract][Full Text] [Related]
12. Selective ablation of symptomatic dominant renal cysts using 99% ethanol in adult polycystic kidney disease.
Singh I; Mehrotra G
Urology; 2006 Sep; 68(3):482-7; discussion 487-8. PubMed ID: 17010722
[TBL] [Abstract][Full Text] [Related]
13. Current treatment status of polycystic liver disease in Japan.
Ogawa K; Fukunaga K; Takeuchi T; Kawagishi N; Ubara Y; Kudo M; Ohkohchi N
Hepatol Res; 2014 Oct; 44(11):1110-8. PubMed ID: 24308726
[TBL] [Abstract][Full Text] [Related]
14. Long-term functional results of aspiration and sclerotherapy with ethanol in patients with autosomal dominant polycystic kidney disease: a non-randomized pilot clinical study.
Küçük EV; Tahra A; Bindayi A; Suçeken FY; Önol FF; Boylu U
Int Urol Nephrol; 2016 Apr; 48(4):457-63. PubMed ID: 26759329
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical instillation of minocycline hydrochloride on cyst size and renal function in polycystic kidney disease.
Uemasu J; Fujiwara M; Munemura C; Tokumoto A; Kawasaki H
Clin Nephrol; 1993 Mar; 39(3):140-4. PubMed ID: 8462201
[TBL] [Abstract][Full Text] [Related]
16. Alcohol sclerosis for polycystic liver disease and obstructive jaundice: use of a nasobiliary catheter.
Dumot JA; Fields MS; Meyer RA; Shay SS; Conwell DL; Brzezinski A
Am J Gastroenterol; 1994 Sep; 89(9):1555-7. PubMed ID: 8079938
[TBL] [Abstract][Full Text] [Related]
17. Treatment of symptomatic polycystic liver disease: transcatheter super-selective hepatic arterial embolization using a mixture of NBCA and iodized oil.
Wang MQ; Duan F; Liu FY; Wang ZJ; Song P
Abdom Imaging; 2013 Jun; 38(3):465-73. PubMed ID: 22743841
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Aspiration Sclerotherapy of Simple Hepatic Cysts: A Systematic Review.
Wijnands TF; Görtjes AP; Gevers TJ; Jenniskens SF; Kool LJ; Potthoff A; Ronot M; Drenth JP
AJR Am J Roentgenol; 2017 Jan; 208(1):201-207. PubMed ID: 27824501
[TBL] [Abstract][Full Text] [Related]
19. Ethanolamine oleate sclerotherapy versus simple cyst aspiration in the management of orbitopalpebral cyst associated with congenital microphthalmos.
Naik MN; Honavar SG; Murthy RK; Raizada K; Thomas R
Ophthalmic Plast Reconstr Surg; 2007; 23(4):307-11. PubMed ID: 17667104
[TBL] [Abstract][Full Text] [Related]
20. Aspiration-sclerotherapy results in effective control of liver volume in patients with liver cysts.
van Keimpema L; de Koning DB; Strijk SP; Drenth JP
Dig Dis Sci; 2008 Aug; 53(8):2251-7. PubMed ID: 18299984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
